ACCC logo
Facebook  LinkedIn  Twitter  ACCC Youtube Channel  ACCCBuzz blog

Association of Community Cancer Centers

The leading education and advocacy organization for the multidisciplinary cancer team

ACCCBuzz Blog  Find a Cancer Program  Log in to MyNetwork

Home > Mediaroom > Press Releases > 2005 > Association of Community Cancer Centers Pleased that GAO Releases its Drug Pricing Report

FOR INFORMATION CONTACT:
Lori Gardner, Senior Director
Communications & Marketing
301.984.9496 ext. 226
lgardner@accc-cancer.org

ACCC News Release

For Immediate Release: July 5, 2005

Association of Community Cancer Centers Pleased that GAO Releases its Drug Pricing Report

GAO Generates Additional Issues for CMS to Consider Before Setting Reimbursement Rates for Hospital Outpatient Departments

ROCKVILLE, Md.—The Association of Community Cancer Centers (ACCC) is pleased that the Government Accountability Office (GAO) released its widely anticipated report on June 30, 2005, on Medicare hospital outpatient department drug purchase prices. To prepare its report, GAO studied the purchase price hospitals pay for 53 specified covered outpatient drug categories. The categories represent 86 percent of all Medicare spending on these drugs in the first nine months of 2004.

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) directed GAO to conduct hospital acquisition cost studies for certain drugs. The Centers for Medicare and Medicaid Services (CMS) then is required to take these survey data into account when setting reimbursement rates for these drugs in hospital outpatient departments in 2006 and beyond.

In an effort to ensure that hospitals are adequately reimbursed and to preserve Medicare beneficiary access to needed cancer therapies, ACCC worked with the GAO as the agency developed and refined its survey instrument.

"Although there may be some drugs for which Medicare currently is paying more than the average purchase price to the hospital, it is important to understand that these payments also reimburse hospitals for the pharmacy overhead and handling costs associated with the administration of these drugs," said Deborah Walter, ACCC's Senior Director, Policy and Government Affairs.

"As the basis for Medicare reimbursement to hospitals for innovative cancer therapies transitions from an average wholesale price to hospital acquisition cost in 2006, it will be imperative that CMS set an appropriate payment rate that accounts for both the acquisition of drug as well as the pharmacy overhead and handling costs associated with its administration," Walter added.

About the Association of Community Cancer Centers
The Association of Community Cancer Centers (ACCC) is the leading advocacy and education organization for the multidisciplinary cancer care team. More than 23,000 cancer care professionals from over 2,000 hospitals and practices nationwide are affiliated with ACCC. It is estimated that 65 percent of the nation's cancer patients are treated by a member of ACCC. Providing a national forum for addressing issues that affect community cancer programs, ACCC is recognized as the premier provider of resources for the entire oncology care team. Our members include medical and radiation oncologists, surgeons, cancer program administrators and medical directors, senior hospital executives, practice managers, pharmacists, oncology nurses, radiation therapists, social workers, and cancer program data managers. For more information, visit ACCC's website at www.accc-cancer.org. Follow us on Facebook, Twitter, LinkedIn, and read our blog, ACCCBuzz.

Copyright © 2017 Association of Community Cancer Centers. All Rights Reserved.
1801 Research Boulevard, Suite 400, Rockville, MD 20850  |  Tel.: 301.984.9496  |  Fax: 301.770.1949

CONTACT US